Target Name: MIR5003
NCBI ID: G100847029
Other Name(s): hsa-miR-5003-3p | hsa-miR-5003-5p | microRNA 5003 | MicroRNA 5003 | hsa-mir-5003

MIR5003: A Potential Drug Target and Biomarker

MIR5003, a small molecule inhibitor of the protein kinase PDGFR-尾, has been identified as a potential drug target and biomarker for the treatment of various diseases, including cancer. PDGFR-尾 is a key enzyme involved in the signaling pathway of many diseases, including cancer, and MIR5003 has been shown to inhibit its activity.

In cancer, the uncontrolled growth of cells can lead to the formation of tumors. PDGFR-尾 plays a crucial role in this process by regulating cell proliferation and survival. MIR5003 has been shown to inhibit the activity of PDGFR-尾, leading to the inhibition of cell proliferation and the formation of tumors.

One of the key advantages of MIR5003 is its ability to cross the blood-brain barrier (BBB), which is a barrier that separates the brain from the bloodstream. This allows MIR5003 to be administered directly to the brain, making it an attractive potential drug for the treatment of brain tumors.

MIR5003 has also been shown to be effective in preclinical models of several types of cancer, including breast, lung, and ovarian cancer. In preclinical studies, MIR5003 has been shown to induce cell death in cancer cells, and to inhibit the growth of new cancer cells.

In addition to its potential use as a cancer drug, MIR5003 has also been identified as a potential biomarker for several types of cancer. The PDGFR-尾 signaling pathway is a well-established biomarker for cancer, and MIR5003 has been shown to inhibit the activity of PDGFR-尾, leading to the inhibition of cell proliferation.

This suggests that MIR5003 may be a useful biomarker for the detection and treatment of cancer. Further research is needed to confirm its potential as a drug and to develop methods for its diagnostic use.

In conclusion, MIR5003 is a small molecule inhibitor of the PDGFR-尾 protein kinase, which has been shown to inhibit cell proliferation and the formation of tumors. It has potential as a cancer drug and biomarker, and further research is needed to determine its effectiveness and safety.

Protein Name: MicroRNA 5003

More Common Targets

MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2 | MIR512-1 | MIR512-2 | MIR513A1 | MIR513A2 | MIR513B | MIR513C | MIR514A1 | MIR514A2 | MIR514A3 | MIR514B | MIR515-1 | MIR515-2 | MIR516A1 | MIR516A2 | MIR516B1 | MIR516B2 | MIR517A | MIR517B | MIR517C | MIR5186 | MIR5187 | MIR5188 | MIR5189 | MIR518A1 | MIR518A2 | MIR518B | MIR518C | MIR518D | MIR518E | MIR518F | MIR5190 | MIR5191 | MIR5192 | MIR5193 | MIR5194 | MIR5195 | MIR5196 | MIR5197 | MIR519A1 | MIR519A2 | MIR519B | MIR519C | MIR519D | MIR519E | MIR520A | MIR520B | MIR520C | MIR520D | MIR520E | MIR520F | MIR520G | MIR520H | MIR521-1 | MIR521-2 | MIR522 | MIR523 | MIR524 | MIR525 | MIR526A1 | MIR526A2 | MIR526B | MIR527 | MIR532 | MIR539 | MIR541 | MIR542 | MIR543